Short Interest in Psychemedics Co. (NASDAQ:PMD) Increases By 187.1%

Psychemedics Co. (NASDAQ:PMD) was the target of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 39,900 shares, an increase of 187.1% from the October 31st total of 13,900 shares. Based on an average daily trading volume, of 26,300 shares, the short-interest ratio is currently 1.5 days. Approximately 0.9% of the company’s shares are short sold.

Psychemedics Trading Down 0.4 %

Shares of PMD traded down $0.01 during trading hours on Wednesday, hitting $2.33. The company had a trading volume of 14,221 shares, compared to its average volume of 17,862. Psychemedics has a 52-week low of $1.63 and a 52-week high of $3.93. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.01. The stock’s 50 day moving average price is $2.32 and its 200 day moving average price is $2.32.

Psychemedics Company Profile

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol.